<DOC>
	<DOCNO>NCT00531895</DOCNO>
	<brief_summary>Background : Although major depression chronic headache strongly associate , insufficient evidence use antidepressant specific comorbidity . This trial aim investigate efficiency tolerability duloxetine indication . Methods : Thirty outpatient clinic , DSM-IV major depression concurrent primary chronic headache ( chronic migraine , chronic tension-type headache ) , 18-55 year , recruit April 2006 March 2007 , score &gt; 21 Montgomery-Ã„sberg Depression Scale ( MADRS ) significant clinical condition . Subjects receive duloxetine 60 mg/day 8 week . MADRS score visual analog pain scale ( VAS ) co-primary outcome measure . WHO quality life scale ( WHOQoL BREF ) score headache days/week secondary outcome measures.Conclusion : In preliminary open trial , duloxetine 60 mg/day effective , fast act well tolerate treatment comorbid major depression chronic headache .</brief_summary>
	<brief_title>An Open Trial Duloxetine Comorbid Major Depression Chronic Headache</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Headache Disorders</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<criteria>Major depression ( accord DSMIV criterion ) MADRS score superior 21 Subjects meet International Headache Society criterion chronic primary headache ( IHSC2 cod 1.5.1 , 1.6.1 , 2.3.1 , 2.3.2 2.4.3 ) ( ICHS , 2003 ) Over 50 % reduction MADRS score washout period Illicit drug alcohol dependence History multiple allergy hypersensitivity duloxetine History epilepsy significant neurological disorder Significant suicide risk Pregnancy lactation Sexually active female subject use efficient contraceptive method Significant laboratory abnormality baseline Significant clinical disease Subjects meeting DSMIV criterion somatisation disorder . ( 300.81 ) present delusional pain symptom .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>major depression</keyword>
	<keyword>chronic headache</keyword>
	<keyword>antidepressant</keyword>
	<keyword>duloxetine</keyword>
</DOC>